Autolus Therapeutics plc (AUTL) Reports Q4 Earnings

[ad_1] AUTL|EPS -$0.34|Rev $24.3M|Net Loss $90.3M Autolus Therapeutics plc (AUTL) posted Q4 2025 Basic and diluted net loss per ordinary share EPS of -$0.34. Revenue totaled $24.3M for the quarter. Revenue of $24.3M was up 83655.2% year-over-year. Autolus Therapeutics plc…



